Treatment patterns and real world clinical outcomes in ER+/HER2- post-menopausal metastatic breast cancer patients in the United States
Crossref DOI link: https://doi.org/10.1186/s12885-017-3379-1
Published Online: 2017-06-02
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zanotti, Giovanni
Hunger, Matthias
Perkins, Julia J
Horblyuk, Ruslan
Martin, Monique
Funding for this research was provided by:
Pfizer (-)